Science Current Events | Science News | Brightsurf.com
 

Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels

May 11, 2012
Results from a randomized trial in head and neck cancer

Barcelona, Spain: Patients with head and neck cancer and a low haemoglobin (Hb) level do not respond well to radiotherapy and therefore both control of their tumour and disease-free survival are compromised. Now researchers from The Netherlands have found that the problems caused by low Hb in these patients can be overcome by the use of a treatment known as ARCON therapy, in which accelerated radiotherapy is combined with carbogen (a mixture of carbon dioxide and oxygen) and the water-soluble vitamin nicotinamide [1].

Hans Kaanders, a professor of translational radiation oncology at Radboud University Nijmegen Medical Centre, Nijmegen, will tell the 31st conference of the European Society for Radiotherapy and Oncology [2] today (Friday) that the ARCON regime is the first to show a positive effect in patients with low Hb levels.

The researchers recruited 345 patients with squamous cell laryngeal cancer to a randomised trial: 174 received only accelerated radiotherapy (where two fractions per day are administered during the last week of radiotherapy in order to reduce the overall length of treatment), and 171 ARCON. Patients receiving ARCON inhaled carbogen during radiotherapy and took nicotinamide tablets prior to treatment. Pre-treatment Hb levels in the experimental group were measured and subsequently compared with the treatment outcomes in the accelerated radiotherapy alone arm.

They found that patients treated with accelerated radiotherapy alone who had normal Hb levels before treatment had significantly better control of the cancer at its primary site (76% as opposed to 56%), disease-free survival (72% and 48% respectively), and metastasis-free survival (90% and 70%) than those with low Hb levels.

"However, when we looked at the ARCON group, in cases where the patients had low Hb levels before treatment, we found that ARCON improved control of the cancer at its primary site, and improved disease-free and metastasis-free survival, so that the differences between them and patients with normal Hb levels were no longer significant," says Professor Kaanders' colleague Dr. Geert Janssens. The difference in local control between this low Hb group and the normal Hb accelerated radiotherapy (AR) alone group was only 1% (81% in the ARCON group versus 82% in the AR-only group); for disease-free survival, the difference was 77% (ARCON) as opposed to 70% (AR); and for metastasis-free survival 93% (ARCON) versus 89% (AR).

However, patients in both groups with low Hb levels pre-treatment still had a worse overall survival irrespective of which treatment they received. This is most likely due the fact that many patients with head and neck cancer also have other health problems that cannot be treated by radiotherapy, the researchers say.

"In the past, a number of investigators have tried to improve the outcome for patients with low Hb levels by giving erythropoietin, which stimulates red blood cell production, and red cell blood transfusion before and during treatment, but without success. ARCON is the first treatment to be found to correct for low Hb and therefore to improve prognosis in these patients," says Dr. Janssens. "We know that a decrease in Hb levels is associated with a reduced sensitivity to radiotherapy, and that this can switch the tumour microenvironment into a more aggressive subtype with a higher risk of loco-regional failure and of the development of distant metastases."

The lack of success with transfusion of red blood cells or erythropoietin suggests underlying adaptive mechanisms. Accelerated radiotherapy to counteract tumour cell repopulation during radiotherapy, combined with carbogen and nicotinamide, administered immediately before irradiation to increase the oxygen level, ensures that adaptive mechanisms cannot erode the effect, and this is probably the key to success of the ARCON regime in patients with low HB levels at presentation, the researchers say.

"We believe that, at a time when healthcare systems are under increasing pressure to introduce expensive targeted treatments, the use of such a low cost, effective therapy should only be encouraged," Professor Kaanders will conclude.

Prof Vincenzo Valentini, radiation oncologist at the Policlinico Universitario A. Gemelli in Rome, Italy, and President of ESTRO, said: "We know that the degree of oxygenation of tumours in laryngeal cancer patients is directly related to the damage that can be caused to them by radiotherapy. This important study shows that, in patients with low haemoglobin levels, it is possible to reoxygenate the tumour by using the simple and cost-effective ARCON regime, and therefore increase the effectiveness of radiation treatment."

###

Abstract no: OC 217, 10.30 hrs, Friday 11 May, Auditorium

[1] When carbogen is inhaled, the increased level of carbon dioxide causes the brain to react to potential suffocation because it interprets the increase in blood carbon dioxide as a decrease in oxygen level, and the body compensates by reducing hypoxia. Nicotinamide also reduces hypoxia by increasing blood flow.

[2] This year the ESTRO conference is held in parallel with the World Congress of Brachytherapy, both taking place in Barcelona from May 9-13.

European Society for Radiotherapy and Oncology (ESTRO)


Related Radiotherapy Current Events and Radiotherapy News Articles


Effect of smoking, alcohol on feeding tube duration in head/neck cancer patients
Current smoking and heavy alcohol consumption appear to be risk factors for prolonged use of a gastrostomy tube (GT, feeding tube) in patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy.

The Lancet: Targeted drug doubles progression free survival in Hodgkin lymphoma
A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell transplant survived without the disease progressing for twice as long as those given placebo (43 months vs 24 months).

The 10-point guide to the integral management of menopausal health
Elsevier journal Maturitas, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) covering the ten- point guide to the integral management of menopausal health.

Agreement on best estimates of breast cancer overdiagnosis urgently needed to inform women
In 2012, prompted by increasing debate about overdiagnosis, an independent UK panel estimated that about 19% of breast cancers diagnosed among women invited to mammogram screening were in fact overdiagnosed (they would have been harmless). But other estimates have been higher (up to 50%) or lower (less than 5%).

Scientists find cancer weak spots for new targeted drugs
Scientists have identified weak spots in cancer cells that could be targeted and attacked by new precision drugs.

Discovery of the genetic fingerprint of aggressive colon tumors
About 40-50% of all colorectal patients relapse in the form of metastasis. In the last three years, several molecular classifications have been proposed to identify colorectal cancer patients at risk of relapse.

Smaller pre-surgery radiation targets reduces long term side effects, not survival rates
Using advanced imaging technology to more precisely target radiation beams to treat soft tissue cancers (sarcomas) in the extremities significantly reduces long term side effects without effecting survival rates, according to research results published online today in the Journal of Clinical Oncology.

Smoking may increase risks for patients being treated for prostate cancer
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or even dying from prostate cancer.

Novel radioguided brain surgery technique could help pinpoint cancerous tissue
A novel radioguided surgery technique could quickly and effectively identify residual cancer cells during brain tumor surgery, with low radiation exposure for both patients and surgeons.

Some older cancer patients can avoid radiotherapy, study finds
Some older women with breast cancer could safely avoid radiotherapy, without harming their chances of survival, a study has shown.
More Radiotherapy Current Events and Radiotherapy News Articles

Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy (Medical Radiology)

Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy (Medical Radiology)
by Nancy Y. Lee (Editor), Nadeem Riaz (Editor), Jiade J. Lu (Editor)


This textbook is designed to help the busy radiation oncologist to accurately and confidently delineate tumor volumes for conformal radiation therapy (including IMRT). The book provides an atlas of clinical target volumes (CTVs) for commonly encountered cancers, with each chapter illustrating CTV delineation on a slice-by-slice basis, on planning CT images. Common anatomic variants for each tumor are represented in individual illustrations, with annotations highlighting differences in coverage. The anatomy of each site and patterns of lymphatic drainage are discussed, and their influence on the design of CTVs is explained in detail. Utilization of other imaging modalities, including MRI, to delineate volumes is highlighted. Key details of simulation and planning are briefly reviewed....

Stereotactic Body Radiotherapy: A Practical Guide

Stereotactic Body Radiotherapy: A Practical Guide
by Andrew Gaya (Editor), Anand Mahadevan (Editor)


This is a single, comprehensive handbook for clinical oncology trainees and consultants, covering the basic aspects of stereotactic radiotherapy systems and treatment.

Basic Radiotherapy Physics and Biology

Basic Radiotherapy Physics and Biology
by David S. Chang (Author), Foster D. Lasley (Author), Indra J. Das (Author), Marc S. Mendonca (Author), Joseph R. Dynlacht (Author)


This book is a concise and well-illustrated review of the physics and biology of radiation therapy intended for radiation oncology residents, radiation therapists, dosimetrists, and physicists. It presents topics that are included on the Radiation Therapy Physics and Biology examinations and is designed with the intent of presenting information in an easily digestible format with maximum retention in mind. The inclusion of mnemonics, rules of thumb, and reader-friendly illustrations throughout the book help to make difficult concepts easier to grasp. Basic Radiotherapy Physics and Biology is a valuable reference for students and prospective students in every discipline of radiation oncology.

Radiation Oncology - A Question Based Review 2nd Edition

Radiation Oncology - A Question Based Review 2nd Edition
by Borislav Hristov (Editor), Steven H. Lin MD PhD (Editor), John P. Christodouleas MD MPH (Editor)


Test and solidify your knowledge of radiation oncology with Radiation Oncology: A Question-Based Review. This book’s Q&A format doesn’t merely encourage rote memorization, but expounds on most answers’ reasoning, background information, and clinical context to foster your complete understanding. Written by top experts, with each chapter authored by at least one resident and one faculty member, Radiation Oncology: A Question-Based Review is the perfect learning tool for students and physicians who are seeking to strengthen their long-term command of radiation oncology.

FEATURESCovers all sites and cancer types currently treated with radiotherapy with an emphasis on treatment recommendations and the evidence behind them.Detailed questions on the natural history,...

Radiotherapy in Prostate Cancer: Innovative Techniques and Current Controversies (Medical Radiology / Radiation Oncology)

Radiotherapy in Prostate Cancer: Innovative Techniques and Current Controversies (Medical Radiology / Radiation Oncology)
by Hans Geinitz (Editor), Mack Roach III (Editor), Nicholas van As (Editor)


Today, the arsenal of “high-precision” or “targeted” radiotherapy includes a variety of techniques and approaches that, like the pieces of a puzzle, need to be put together to provide the prostate cancer patient with high-level optimized radiation treatment. This book examines in detail the role of these innovative radiation techniques in the management of prostate cancer. In addition, a variety of current controversies regarding treatment are carefully explored, including whether prophylactic treatment of the pelvic lymphatics is essential, the magnitude of the effect of dose escalation, whether a benefit accrues from hypofractionation, and what evidence exists for the superiority of protons or heavy ions. Radiotherapy in Prostate Cancer: Innovative Techniques and Current...

Khan's The Physics of Radiation Therapy

Khan's The Physics of Radiation Therapy
by Faiz M. Khan PhD (Author), John P. Gibbons PhD (Author)


Expand your understanding of the physics and practical clinical applications of advanced radiation therapy technologies with Khan's The Physics of Radiation Therapy, 5th edition, the book that set the standard in the field. This classic full-color text helps the entire radiation therapy team—radiation oncologists, medical physicists, dosimetrists, and radiation therapists—develop a thorough understanding of 3D conformal radiotherapy (3D-CRT), stereotactic radiosurgery (SRS), high dose-rate remote afterloaders (HDR), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), Volumetric Modulated Arc Therapy (VMAT), and proton beam therapy, as well as the physical concepts underlying treatment planning, treatment delivery, and dosimetry.

In preparing...

Perez & Brady's Principles and Practice of Radiation Oncology (Perez and Bradys Principles and Practice of Radiation Oncology)

Perez & Brady's Principles and Practice of Radiation Oncology (Perez and Bradys Principles and Practice of Radiation Oncology)
by Edward C. Halperin MD (Author), Luther W. Brady MD (Author), Carlos A. Perez MD (Author), David E. Wazer MD (Author)


Inside the Sixth Edition of this now-classic reference, you will discover encyclopedic coverage of topics ranging from basic science to sophisticated computer-based radiation therapy treatment planning and supportive care. The book’s comprehensive scope and abundantly illustrated format provide you with better understanding of the natural history of cancer, the physical methods of radiation application, the effects of radiation on normal tissues, and the most judicious ways in which you can employ radiation therapy in patient care. Traditionally available as a printed textbook, now it comes with a completely revamped digital experience, powered by Inkling! NEW to the Sixth Edition…• Site-specific chapters include relevant background information on each tumor—including...

PET-CT in Radiotherapy Treatment Planning, 1e

PET-CT in Radiotherapy Treatment Planning, 1e
by Arnold C. Paulino MD (Author)


Here is an exciting new guide to the use of PET-CT imaging in radiotherapy. You'll get practical, useful information for utilizing this novel imaging technique-from different methods for contouring biological target volumes in various anatomic regions to how different experts use this imaging in targeted treatment. This thorough text helps you make concise, accurate treatment choices based on current evidence and expert authority. The result is an essential tool for everyone on the radiotherapy treatment team in the era of image-guided radiotherapy.Helps familiarize you with the basics of PET imaging in nuclear medicine. Covers the use of PET-CT with radiotherapy treatment planning, offering practical guidance in how different experts use this relatively new technology. Highlights...

Clinical Radiation Oncology, 4e

Clinical Radiation Oncology, 4e
by Leonard L. Gunderson MD MS FASTRO (Author), Joel E. Tepper MD (Author)




Radiotherapy Physics: In Practice

Radiotherapy Physics: In Practice
by J. R. Williams (Editor), D. I. Thwaites (Editor)


Radiotherapy has been one of the principal modalities for the treatment of malignant disease for more than 50 years. From the outset, its advancement has depended on the work of physicists and engineers, in particular for the development of high-energy accelerators for X-ray and electron beams, and in the production of radioactive sources. In addition, the clinical application of ionizing radiations for therapy is based on the foundation of dosimetric concepts and instrumentation. Medical physics plays a pivotal role in many areas, including treatment equipment, dosimetry, treatment planning, and radiation protection.

Radiotherapy physics, second edition is a comprehensive, practical introduction to radiotherapy physics. It provides detailed descriptions of current techniques,...

© 2015 BrightSurf.com